prikaz prve stranice dokumenta Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma
  Preuzmi
PDF 2.25 MB
Znanstveni rad - Izvorni znanstveni rad
Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma
Pathology - Research and Practice, 239 (2022); 154170. https://doi.org/10.1016/j.prp.2022.154170
Pavlov, Katarina Horvat; Tadić, Vanja; Palković, Pamela Bašić; Sasi, Biljana; Magdić, Nives; Petranović, Matea Zajc; Klasić, Marija; Hančić, Suzana; Gršković, Paula; Matulić, Maja; Gašparov, Slavko; Dominis, Mara; Korać, Petra

Citirajte ovaj rad

Pavlov, K. H., Tadić, V., Palković, P. B., Sasi, B., Magdić, N., Petranović, M. Z. ... Korać, P. (2022). Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma. Pathology - Research and Practice, 239., 154170. doi: 10.1016/j.prp.2022.154170

Pavlov, Katarina Horvat, et al. "Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma." Pathology - Research and Practice, vol. 239, 2022, str. 154170. https://doi.org/10.1016/j.prp.2022.154170

Pavlov, Katarina Horvat, Vanja Tadić, Pamela Bašić Palković, Biljana Sasi, Nives Magdić, Matea Zajc Petranović, Marija Klasić, et al. "Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma." Pathology - Research and Practice 239 (2022): 154170. https://doi.org/10.1016/j.prp.2022.154170

Pavlov, K. H., et al. (2022) 'Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma', Pathology - Research and Practice, 239, str. 154170. doi: 10.1016/j.prp.2022.154170

Pavlov KH, Tadić V, Palković PB, Sasi B, Magdić N, Petranović MZ, i sur.. Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma. Pathology - Research and Practice [Internet]. 11.2022. [pristupljeno 27.01.2025.];239:154170. doi: 10.1016/j.prp.2022.154170

K. H. Pavlov, et al., "Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma", Pathology - Research and Practice, vol. 239, str. 154170, Studeni 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:264:495235. [Citirano: 27.01.2025.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:264:495235
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Different expression of DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN and EP300 genes in lymphomagenesis of low vs. high grade lymphoma
AutorKatarina Horvat Pavlov
AutorVanja Tadić
AutorPamela Bašić Palković
AutorBiljana Sasi
AutorNives Magdić
AutorMatea Zajc Petranović
AutorMarija Klasić
AutorSuzana Hančić https://orcid.org/0000-0001-7864-7996
AutorPaula Gršković
AutorMaja Matulić
AutorSlavko Gašparov
AutorMara Dominis
AutorPetra Korać
Autorova ustanova(Klinička bolnica Merkur)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Sažetak (engleski)
Tumour cells develop by accumulating changes in the genome that result in changes of main cellular processes. Aberrations of basic processes such as replication and chromatin reassembly are particularly important for genomic (in)stability. The aim of this study was to analyse the expression of genes whose products are crucial for the regulation of replication and chromatin reassembly during lymphomagenesis (DNMT1, PCNA, MCM2, CDT1, EZH2, GMNN, EP300). Non-tumour B cells were used as a control, and follicular lymphoma (FL) and the two most common groups of diffuse large B cell lymphoma (DLBCL) samples were used as a model for tumour progression. The results showed that there are significant changes in the expression of the analysed genes in lymphomagenesis, but also that these changes do not display linearity when assessed in relation to the degree of tumour aggression. Additionally, an integrated bioinformatics analysis of the difference in the expression of selected genes between tumour and non-tumour samples, and between tumour samples (FL vs. DLBCL) in five GEO datasets, did not show a consistent pattern of difference among the datasets
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaPathology - Research and Practice
Brojčani podacivol. 239, str. 154170
p-ISSN0344-0338
DOIhttps://doi.org/10.1016/j.prp.2022.154170
URN:NBNurn:nbn:hr:264:495235
Datum objave publikacije2022-11
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S0344033822004149
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2024-12-10 08:12:45